The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study

Peter Kardos,1 Ina Hagedorn-Peinz2 1Pulmonary Department, Respiratory and Sleep Medicine at Red Cross Maingau Hospital, Group Practice Allergy, Frankfurt, Germany; 2Novartis Pharma GmbH, Nuremberg, Germany Background: The objective of the FAVOR study was to evaluate the effect of indacaterol/glyco...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Kardos P, Hagedorn-Peinz I
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Dove Medical Press 2017-12-01
Seri Bilgileri:	International Journal of COPD
Konular:	COPD dual-bronchodilators FEV1 indacaterol/glycopyrronium treatment preference treatment satisfaction
Online Erişim:	https://www.dovepress.com/the-impact-of-indacaterolglycopyrronium-fixed-dose-combination-versus--peer-reviewed-article-COPD
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!